No definition available.
Human immunodeficiency virus [HIV] disease resulting in other conditions
AB1_OTHER_CONDITIONS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
646 |
4. Check minimum number of eventsNone |
646 |
5. Include endpointsNone |
646 |
6. Filter based on genotype QC (FinnGen only) |
646 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease resulting in other conditions
based on the number of shared cases.
Similar with more cases:
- Human immunodeficiency virus [HIV] disease
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2761 | 677 | 1897 |
| Only index persons | 2352 | 643 | 1709 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.02 | 0.05 |
| Only index persons | 0.05 | 0.02 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 37.99 | 33.57 | 39.95 |
| Only index persons | 38.02 | 33.45 | 39.74 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 646 | 147 | 499 |
| Unadjusted period prevalence (%) | 0.18 | 0.05 | 0.22 |
| Median age at first event (years) | 38.38 | 35.35 | 39.28 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 590
- Matched controls
- 5898
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
323.0
572
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
323.0
299
*
WW200
NOMESCO Finland
Immunization
417.6
323.0
486
65
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
32.9
249.4
354
257
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
217.5
195
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
179.6
163
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
28.0
141.5
199
105
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
12.2
104.3
208
251
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
842.0
77.1
74
*
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
76.8
72
*
A51.0
ICD-10 Finland
Primary genital syphilis
+∞
61.5
58
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
8.6
49.3
114
160
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
47.5
45
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
471.6
44.9
44
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
43.1
318
1501
A54.5
ICD-10 Finland
Gonococcal pharyngitis
197.0
36.2
37
*
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
6.3
36.0
102
188
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
35.8
34
*
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
14.5
34.0
58
44
A63.0
ICD-10 Finland
Anogenital (venereal) warts
7.8
31.1
74
106
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.0
30.3
106
249
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
317.8
30.1
30
*
A53.9
ICD-10 Finland
Syphilis, unspecified
152.2
27.9
29
*
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
3.0
24.9
175
729
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
24.1
23
*
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
9.3
23.3
49
57
ULA02
NOMESCO Finland
Kolposcopy
5.4
22.7
71
146
K02.9
ICD-10 Finland
Dental caries, unspecified
12.5
22.3
40
34
B18.2
ICD-10 Finland
Chronic viral hepatitis C
7.8
21.8
51
71
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
21.1
82
212
J05AB01
ATC
aciclovir; systemic
3.0
21.1
143
575
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.8
21.0
160
692
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
217.3
20.7
21
*
WYA30
SPAT
NA
21.0
20.6
30
15
F43.29
ICD-10 Finland
Adaptation disorder UNS
9.1
20.0
42
49
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
19.4
115
417
J05AB11
ATC
valaciclovir; oral
3.4
19.1
101
339
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
195.9
18.6
19
*
TAB00
NOMESCO Finland
Lumbar puncture
5.5
17.9
54
106
SPAT1263
SPAT
Sampling
0.3
17.8
60
1482
R4110
NOMESCO Finland
Physiotherapy
2.4
17.5
177
885
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.4
17.3
53
106
Z01.2
ICD-10 Finland
Dental examination
2.1
17.0
271
1671
B90
ICPC
HIV-infection/AIDS
+∞
16.7
16
*
K02.2
ICD-10 Finland
Caries of cementum
5.3
16.2
50
101
Y25
ICPC
Fear sexually transm disease male
5.6
16.1
47
89
B02.9
ICD-10 Finland
Zoster without complication
6.1
15.7
43
75
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
15.7
15
*
C10AA07
ATC
rosuvastatin; oral
2.4
15.6
152
738
S02.51
ICD-10 Finland
Fracture of tooth, open
3.2
15.5
88
309
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
11.7
15.4
28
25
SPAT1301
SPAT
No procedures
0.3
15.4
27
922
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
15.2
112
466
R50.9
ICD-10 Finland
Fever, unspecified
2.8
14.9
103
412
N05CF01
ATC
zopiclone; oral
2.2
14.5
186
1027
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
37.0
14.5
18
5
ZX114
NOMESCO Finland
Intramuscular
8.0
14.3
32
42
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.3
14.2
29
921
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.0
13.9
57
154
UJF30
NOMESCO Finland
Ileoscopy through colon
3.3
13.8
73
243
EB1AA
SPAT
NA
4.1
13.5
54
143
N05CD07
ATC
temazepam; oral
3.1
13.4
76
267
SPAT1153
SPAT
Removal of sutures
0.3
12.6
34
950
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
17.8
12.6
19
11
SPAT1249
SPAT
Treatment-related counselling outside office
0.4
12.6
64
1364
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
12.5
12
*
WX110
SPAT
NA
3.7
12.0
53
154
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.6
12.0
96
417
R74
ICPC
Upper respiratory infection acute
2.0
11.9
184
1082
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
8.7
11.9
25
30
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
11.9
43
104
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
11.8
150
813
D11
ICPC
Diarrhoea
2.7
11.7
85
348
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.4
11.7
69
1395
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
23.4
11.6
16
7
C10AA01
ATC
simvastatin; oral
0.4
11.5
50
1142
SPAT1310
SPAT
Counselling related to known health issue
0.4
11.5
41
1013
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
11.5
11
*
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
+∞
11.5
11
*
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
6.8
11.4
28
43
A01AB04
ATC
amphotericin B; local oral
5.3
11.1
33
65
TQW99
NOMESCO Finland
Other minor procedure on skin
4.5
11.0
38
88
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
10.5
35
78
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
14.5
10.5
17
12
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
10.4
10
*
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
10.4
10
*
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
10.4
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
10.3
88
394
D07AB08
ATC
desonide; topical
2.7
9.9
68
267
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
9.9
112
573
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
9.7
114
594
M01AC06
ATC
meloxicam; systemic, rectal
0.5
9.6
68
1303
UJH02
NOMESCO Finland
Anoscopy
4.0
9.6
37
96
KMAK
NOMESCO Finland
NA
1.7
9.4
340
2602
B23.2
ICD-10 Finland
HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
+∞
9.4
9
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
22.1
9.4
13
6
Z71.8
ICD-10 Finland
Other specified counselling
2.0
9.3
140
805
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.4
9.3
82
371
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.3
9.2
28
746
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
9.2
9.1
18
20
SPAT1312
SPAT
General health counselling
0.4
8.9
44
960
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
8.8
55
206
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.0
8.8
34
89
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.1
8.7
49
169
D82
ICPC
Teeth/gum disease
0.5
8.7
87
1500
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
14.3
8.7
14
10
SPAT1097
SPAT
Recording of ECG
0.1
8.5
5
336
N05BA01
ATC
diazepam; systemic, rectal
2.3
8.5
80
376
ZXA05
NOMESCO Finland
Left side
1.9
8.5
128
734
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
8.4
43
141
Z30.2
ICD-10 Finland
Sterilization
0.2
8.4
7
374
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
91.3
8.4
9
*
-1
NOMESCO Finland
NA
1.7
8.3
209
1418
J01MA12
ATC
levofloxacin; systemic
2.1
8.3
105
561
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
8.3
85
416
WX290
SPAT
NA
3.9
8.2
32
85
J01MA02
ATC
ciprofloxacin; systemic
1.7
8.1
206
1400
WNF00
NOMESCO Finland
Infection source and contact determination
17.5
8.1
12
7
ZXA00
NOMESCO Finland
Right side
1.9
7.9
130
768
SPAT1324
SPAT
Screening procedure
0.2
7.8
7
357
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
7.6
7.7
17
23
N06AB04
ATC
citalopram; systemic
1.9
7.6
118
682
SPAT1149
SPAT
Suture or treatment of traumatic wound
0.2
7.5
8
368
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
7.8
7.4
16
21
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.8
7.4
130
784
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
7.3
7
*
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
7.3
7
*
B21.0
ICD-10 Finland
HIV disease resulting in Kaposi sarcoma
+∞
7.3
7
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
7.3
7
*
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
7.3
7
*
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
7.3
7
*
A51.4
ICD-10 Finland
Other secondary syphilis
+∞
7.3
7
*
D01AE16
ATC
amorolfine; topical
2.4
7.2
61
270
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.3
7.2
11
414
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
4.1
7.2
26
65
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.3
7.1
34
107
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
8.1
7.1
15
19
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
12.2
7.1
12
10
JN4BD
NOMESCO Finland
Extensive body CT
2.4
7.0
57
248
D06BB04
ATC
podophyllotoxin; topical
2.6
7.0
51
210
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.4
6.9
57
252
B17.1
ICD-10 Finland
Acute hepatitis C
16.9
6.8
10
6
N05BA04
ATC
oxazepam; oral
1.8
6.7
126
775
5AB01
NOMESCO Finland
NA
22.8
6.7
9
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.2
6.7
9
363
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
6.6
86
464
M01AH05
ATC
etoricoxib; oral
0.6
6.6
211
2765
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
12.4
6.6
11
9
SPAT1216
SPAT
Assessment of functional ability
0.2
6.5
5
284
Z01.7
ICD-10 Finland
Laboratory examination
2.2
6.5
64
306
D06BB10
ATC
imiquimod; topical
3.6
6.5
27
77
B59
ICD-10 Finland
Pneumocystosis
70.6
6.4
7
*
A52.9
ICD-10 Finland
Late syphilis, unspecified
70.6
6.4
7
*
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
70.6
6.4
7
*
HMAK
NOMESCO Finland
NA
0.3
6.4
13
422
P01AB01
ATC
metronidazole; oral, rectal
1.6
6.4
185
1288
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
6.4
57
263
K05.31
ICD-10 Finland
Periodontitis pronounced
2.2
6.4
63
301
OAB43
SPAT
NA
0.5
6.3
49
925
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
6.3
61
291
C10AA05
ATC
atorvastatin; oral
0.5
6.3
71
1198
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.4
6.3
24
585
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
6.3
6
*
Y71
ICPC
Gonorrhoea male
+∞
6.3
6
*
TLC02
NOMESCO Finland
Simple extraction of IUD
3.9
6.2
24
64
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.1
6.2
*
231
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
6.2
88
493
T74.1
ICD-10 Finland
Physical abuse
4.2
6.1
21
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
617
17
8063.55
307.65
16.2
1.2
3067.1
—
u/ml
—
381
0
499
469
43.36
307.65
2.5
3.1
27.7
141.1
u/l
0.61
494
418
556
23
1728.97
307.65
3.0
2.9
31.2
41.6
%
—
91
8
479
43
428.04
307.65
2.3
2.3
926.6
716.7
e6/l
1.12
13
24
524
1345
16.33
240.11
1.9
1.7
1.4
1.6
mmol/l
2.33
519
1158
111
13
102.89
213.93
3.3
1.6
—
—
—
0
0
625
2394
50.55
186.98
18.9
6.3
2.9
3.0
%
0.45
625
2276
133
60
27.65
186.49
1.1
1.1
—
—
—
0
0
626
2456
51.03
181.08
18.7
6.1
50.0
56.9
%
54.92
626
2345
626
2489
49.94
177.54
18.9
6.3
36.5
28.3
%
77.29
626
2373
633
2642
70.37
168.32
18.8
6.3
2.2
1.9
e9/l
10.17
625
2366
197
238
11.47
160.03
5.9
1.7
—
—
—
0
0
584
2321
16.80
157.61
7.1
4.1
0.0
0.0
estimate
0.50
41
438
584
2324
16.76
157.30
4.0
2.9
0.0
0.0
estimate
0.00
41
419
585
2336
16.93
156.91
4.0
2.9
0.0
0.0
estimate
0.00
37
393
634
2898
64.94
145.87
19.8
9.8
3.1
4.1
e9/l
49.80
626
2546
205
299
9.58
142.80
6.0
1.8
—
—
—
0
0
637
3764
50.68
124.22
11.9
7.9
75.8
77.1
u/l
0.46
637
3582
148
177
10.55
119.34
3.1
3.3
1.2
1.4
mg/l
2.89
141
167
142
177
10.00
110.59
1.2
1.3
178.9
227.8
miu/ml
0.57
49
83
346
1220
4.95
90.21
3.1
2.9
0.1
0.4
e6/l
2.98
253
903
236
685
4.85
76.87
4.3
1.8
—
—
—
0
0
249
760
4.70
75.96
4.9
1.9
—
—
—
0
0
49
16
33.06
75.37
5.4
1.8
—
—
—
0
0
61
44
15.20
67.29
4.5
2.0
9.8
12.6
%
—
5
19
57
37
16.80
66.48
5.2
2.1
—
—
—
0
0
224
706
4.33
64.10
2.6
2.7
1.9
1.3
e6/l
0.33
98
365
227
751
4.12
60.29
2.6
2.6
1.1
1.1
e6/l
0.07
101
410
355
1600
3.71
59.25
3.3
3.1
—
—
—
0
0
57
50
12.41
55.84
2.1
1.8
—
—
—
0
0
637
5030
20.12
51.87
22.0
10.8
88.6
89.2
ml/min/173m2
0.39
616
4182
102
199
5.90
51.38
1.4
1.4
—
—
—
0
0
633
4525
20.82
51.01
27.8
14.8
13.3
13.5
%
4.11
633
4444
90
175
5.81
45.32
1.1
1.7
0.2
0.1
iu/ml
0.31
54
30
78
163
5.31
36.08
2.6
1.7
—
—
—
0
0
622
4841
8.67
33.62
8.5
4.9
35.2
39.3
mmol/mol
33.19
622
4622
35
34
10.83
31.81
6.7
3.4
46.3
25.3
mu/l
1.94
35
34
24
12
20.73
31.18
1.2
1.2
—
—
—
0
0
73
168
4.77
30.05
1.4
1.8
1.2
1.5
g/l
2.10
64
154
49
82
6.38
28.51
1.2
1.3
—
—
—
0
0
49
82
6.38
28.51
1.2
1.3
—
—
—
0
0
37
45
8.66
28.50
3.0
2.5
977.5
797.7
e6/l
0.36
27
38
509
3627
2.90
27.83
3.9
3.8
10.8
9.1
mm/h
2.01
502
3423
27
24
11.70
25.94
3.7
2.6
—
—
—
0
0
184
848
2.64
25.08
1.4
1.5
18.8
20.0
nmol/l
0.84
176
755
35
49
7.49
23.96
4.3
3.8
—
—
—
0
0
107
385
3.13
23.00
2.2
2.4
77.5
73.6
ml/min/173m2
0.57
55
146
626
5298
6.86
21.25
28.7
12.5
42.4
42.0
%
1.25
596
4367
19
13
15.03
21.13
2.2
1.8
—
—
iu/ml
—
0
0
254
1492
2.16
18.98
4.4
3.5
9.1
9.0
mmol/l
0.03
240
1290
639
5817
10.09
18.65
22.3
9.5
32.8
32.4
u/l
0.22
639
5681
28
41
7.09
18.38
1.1
1.0
—
—
—
0
0
20
20
10.29
17.67
1.0
1.2
30.6
25.1
umol/l
1.83
20
20
616
5307
4.46
16.85
13.5
12.2
23.6
22.9
mg/l
0.19
460
4118
71
280
2.73
12.70
1.7
1.3
—
—
—
0
0
244
1587
1.86
12.44
1.7
1.8
94.5
96.3
pmol/l
0.31
138
908
162
932
1.99
11.89
2.1
2.0
2.5
2.9
mg/l
1.07
140
822
98
1815
0.46
11.64
2.5
3.0
23.3
38.7
ng/l
0.87
41
1123
96
482
2.16
10.05
1.6
1.9
—
—
—
0
0
34
100
3.53
10.00
4.0
3.8
2.9
4.2
e9/l
5.79
34
100
337
4201
0.59
9.94
3.0
3.3
56.7
52.7
u/l
0.37
320
4019
33
96
3.57
9.87
2.3
1.8
—
—
—
0
0
34
101
3.50
9.86
4.0
4.2
48.7
56.4
%
3.51
34
101
96
491
2.12
9.57
1.6
1.9
—
—
—
0
0
44
159
2.90
9.26
1.3
1.1
—
—
—
0
0
44
159
2.90
9.26
1.3
1.1
—
—
—
0
0
43
156
2.88
8.99
2.4
3.3
—
—
—
0
0
83
422
2.11
8.38
1.5
1.5
—
—
—
0
0
16
30
5.44
8.24
1.7
3.6
1365.3
620.2
u/ml
1.12
16
30
11
523
0.20
8.17
7.8
6.1
—
—
—
0
0
31
812
0.35
8.08
1.4
1.8
—
—
—
0
0
11
5
22.34
8.03
4.5
1.4
—
—
—
0
0
116
1849
0.55
8.00
4.8
2.9
—
—
—
0
0
53
237
2.35
7.30
1.5
1.6
—
—
—
0
0
639
6128
4.95
6.96
29.7
17.4
143.1
142.6
g/l
0.35
639
6066
63
310
2.14
6.91
1.4
1.5
—
—
—
0
0
16
37
4.41
6.52
2.8
2.2
—
—
—
0
0
81
449
1.92
6.41
1.8
2.5
0.3
0.2
g/l
1.67
75
418
28
99
2.91
6.17
2.1
4.0
—
2809.3
—
0
10
34
134
2.62
6.13
1.2
1.5
—
—
—
0
0
251
1903
1.52
6.04
6.4
7.2
1.2
1.2
mmol/l
0.21
242
1765
75
415
1.91
5.97
2.7
3.5
0.3
1.9
mmol/l
2.45
60
339
99
602
1.76
5.83
2.3
3.1
9.6
9.0
umol/l
0.12
86
542
131
892
1.59
4.98
3.0
3.5
81.3
660.5
ng/l
3.34
92
657
52
271
2.00
4.94
2.0
4.4
75.2
88.8
ng/l
0.92
52
250
167
2184
0.68
4.30
3.1
3.9
—
—
—
0
0
16
51
3.19
4.23
1.3
1.5
—
—
—
0
0
203
2554
0.70
4.18
3.3
3.5
2.1
1.7
ug/l
0.47
190
2362
259
2096
1.39
4.00
6.0
7.8
1.2
1.2
mmol/l
0.49
235
1807
11
28
3.98
3.99
1.0
1.0
12.2
4.6
iu/ml
—
5
8
155
2033
0.69
3.98
2.6
3.2
24.4
21.4
%
0.71
55
716
79
1181
0.62
3.82
5.8
3.2
0.0
0.0
estimate
0.80
41
413
8
255
0.31
3.78
2.0
1.7
—
—
—
0
0
138
1011
1.46
3.67
1.6
1.5
—
—
—
0
0
7
9
7.85
3.56
1.1
3.9
—
—
—
0
0
6
212
0.28
3.55
2.7
3.2
24.9
24.7
mmol/l
—
6
207
0
89
0.00
3.52
0.0
1.8
—
—
—
0
0
99
686
1.52
3.45
1.6
1.9
—
—
—
0
0
69
450
1.60
3.14
2.9
3.2
—
—
—
0
0
21
92
2.33
3.13
2.1
1.6
—
—
—
0
0
218
1775
1.34
3.07
2.2
2.3
73.1
72.5
nmol/l
0.10
211
1645
16
63
2.58
2.97
1.4
1.3
—
—
—
0
0
22
101
2.22
2.96
2.2
1.5
—
—
—
0
0
0
80
0.00
2.94
0.0
1.8
—
—
—
0
0
12
41
2.96
2.87
1.5
2.9
—
—
—
0
0
53
812
0.62
2.82
1.6
1.6
405.9
36783642.0
pmol/l
0.97
46
715
11
36
3.09
2.82
1.2
1.1
—
—
—
0
0
43
257
1.72
2.75
17.7
15.0
24.1
24.6
mmol/l
0.49
37
247
8
19
4.25
2.68
1.0
1.4
15.1
14.5
u/l
—
8
19
33
185
1.83
2.62
1.9
2.6
94.1
92.9
%
0.12
33
177
10
33
3.06
2.53
1.0
1.1
720.0
193.2
iu/ml
—
10
33
80
1091
0.70
2.41
2.5
3.1
949.3
948.9
ng/l
0.00
71
903
6
12
5.04
2.40
1.0
2.0
—
—
—
0
0
6
12
5.04
2.40
1.2
1.3
—
—
—
0
0
440
4024
1.29
2.39
3.6
3.1
—
—
—
0
0
9
29
3.13
2.23
1.0
1.2
—
—
—
0
0
15
308
0.47
2.22
1.9
3.2
4.7
5.2
kpa
3.09
15
291
138
1100
1.32
2.18
1.3
1.3
2.9
1.6
u/ml
0.36
12
330
21
109
1.96
2.12
1.0
1.2
—
—
—
0
0
60
841
0.68
2.10
1.3
1.2
22.7
25.9
iu/ml
0.10
17
261
228
1953
1.26
2.05
2.4
2.7
150.8
152.6
ug/l
0.03
219
1860
14
63
2.25
2.02
1.7
1.3
—
—
—
0
0
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
15
70
2.17
1.99
1.1
1.2
—
—
—
0
0
15
291
0.50
1.91
1.9
3.3
0.3
1.6
mmol/l
—
7
216
112
1396
0.76
1.88
1.7
2.5
3531.4
4078.6
umol/l
0.06
97
1275
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
129
1.81
1.88
2.2
3.5
0.5
0.3
u/ml
—
9
73
92
717
1.33
1.71
2.5
2.4
31.1
29.9
s
1.42
92
701
163
1370
1.25
1.69
3.5
4.2
13.4
9.8
mg/mmol
0.35
118
933
18
97
1.88
1.67
1.4
1.5
—
—
—
0
0
18
97
1.88
1.67
1.3
1.5
—
—
—
0
0
18
97
1.88
1.67
1.3
1.5
—
—
—
0
0
18
97
1.88
1.67
1.3
1.5
—
—
—
0
0
6
19
3.18
1.66
1.2
2.5
—
—
—
0
0
6
19
3.18
1.66
1.2
2.5
—
—
—
0
0
10
43
2.35
1.61
1.5
2.4
—
—
—
0
0
25
152
1.67
1.59
1.1
1.1
—
—
—
0
0
22
130
1.72
1.55
1.0
1.2
371.9
235.3
u/ml
0.80
15
85
17
93
1.85
1.53
2.1
4.2
4.3
133.7
u/ml
0.49
17
88
7
27
2.61
1.52
1.0
1.0
1932.6
1396.0
miu/ml
—
7
27
8
167
0.47
1.49
1.1
2.1
—
—
—
0
0
57
423
1.38
1.46
1.8
1.9
49.5
36.7
nmol/l
2.26
57
416
7
28
2.52
1.45
1.0
1.1
—
—
—
0
0
25
384
0.64
1.41
1.8
2.1
9.1
9.3
ug/l
0.02
20
360
7
29
2.43
1.39
2.7
2.1
—
411.8
—
0
5
60
782
0.74
1.39
1.3
1.2
20.3
8.7
u/ml
0.30
13
334
18
104
1.75
1.38
1.4
1.6
—
—
—
0
0
22
135
1.65
1.37
1.8
2.5
174.3
128.4
ug/min
0.21
15
76
0
37
0.00
1.34
0.0
1.2
—
—
—
0
0
18
105
1.73
1.34
2.8
4.3
4.7
5.1
kpa
1.98
18
105
0
39
0.00
1.34
0.0
2.1
—
—
—
0
0
11
54
2.06
1.33
1.1
1.3
—
—
—
0
0
0
40
0.00
1.33
0.0
1.3
—
1.1
—
0
16
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
77
611
1.30
1.29
1.6
1.6
871.4
1161.6
nmol/l
2.63
67
488
22
139
1.60
1.24
1.1
1.2
—
—
—
0
0
22
140
1.59
1.21
1.1
1.3
536.5
499.2
mg/l
0.22
22
133
131
1115
1.22
1.21
1.9
1.8
2.2
1.1
mg/l
0.42
101
845
6
26
2.32
1.19
1.3
3.3
—
63716.1
—
0
7
0
34
0.00
1.16
0.0
2.2
—
—
—
0
0
13
222
0.58
1.16
2.1
2.6
0.1
0.1
e6/l
0.07
13
214
0
36
0.00
1.14
0.0
1.1
—
98.6
—
0
28
10
51
1.98
1.11
1.2
2.5
—
—
—
0
0
103
866
1.23
1.08
2.3
2.4
17.3
14.3
nmol/l
3.17
97
796
81
669
1.24
1.01
3.4
3.2
2.4
2.4
mmol/l
0.10
64
596
0
30
0.00
0.97
0.0
2.2
—
—
—
0
0
549
5322
1.21
0.97
14.6
13.7
3.9
4.0
mmol/l
8.42
535
5201
0
31
0.00
0.96
0.0
2.2
—
—
—
0
0
6
116
0.51
0.95
1.2
1.3
—
—
—
0
0
11
62
1.79
0.94
1.1
1.1
—
—
—
0
0
11
62
1.79
0.94
1.1
1.5
—
—
—
0
0
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
8
45
1.79
0.84
1.0
1.0
—
—
—
0
0
8
137
0.58
0.84
1.0
1.2
—
18.2
—
0
17
14
89
1.59
0.81
1.0
1.1
—
—
—
0
0
13
82
1.60
0.78
1.0
1.1
—
—
—
0
0
0
27
0.00
0.77
0.0
3.4
—
—
—
0
0
17
115
1.49
0.77
1.4
2.4
49.8
37.8
mg/l
0.62
17
82
0
28
0.00
0.76
0.0
1.9
—
—
—
0
0
0
28
0.00
0.76
0.0
3.2
—
80.8
—
0
28
15
99
1.53
0.76
1.5
1.3
1.3
4.3
u/ml
—
8
34
5
26
1.93
0.70
4.8
1.8
—
—
—
0
0
22
161
1.38
0.69
1.5
1.2
—
—
—
0
0
28
214
1.32
0.68
1.2
1.4
15.8
20.6
iu/l
0.47
17
180
7
43
1.63
0.67
1.1
1.2
—
—
—
0
0
7
43
1.63
0.67
1.1
1.2
—
—
—
0
0
138
1523
0.88
0.65
2.2
2.4
0.7
0.7
ug/l
0.04
102
778
90
791
1.16
0.62
2.4
4.0
0.8
0.8
mmol/l
0.13
79
756
6
103
0.58
0.62
1.0
2.0
—
—
—
0
0
14
96
1.47
0.62
1.6
1.6
1109.0
10365.9
e6/l
—
5
69
5
30
1.67
0.61
1.4
2.8
106.2
90.3
%
—
5
30
542
5297
1.14
0.60
13.8
13.7
139.1
139.7
mmol/l
6.95
530
5180
17
230
0.73
0.58
1.7
2.4
0.6
0.7
%
0.29
17
225
16
115
1.40
0.57
1.2
2.4
42.2
33.8
mg/l
0.42
16
83
6
36
1.67
0.57
1.0
1.2
—
—
—
0
0
6
37
1.63
0.55
1.0
1.5
5.1
8.8
u/l
—
6
31
8
123
0.65
0.55
1.0
2.1
—
—
—
0
0
11
74
1.49
0.53
1.1
1.1
—
—
—
0
0
113
1027
1.12
0.50
2.2
2.1
1.6
1.5
%
1.44
100
932
10
144
0.69
0.49
1.0
1.2
—
35.5
—
0
5
7
111
0.63
0.48
1.0
1.1
—
—
—
0
0
146
1351
1.10
0.47
5.3
3.5
2.4
2.3
mmol/l
0.45
130
1227
15
113
1.34
0.43
1.1
2.4
—
1.1
—
0
11
10
70
1.44
0.42
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
9.2
—
0
18
0
18
0.00
0.40
0.0
2.0
—
—
—
0
0
7
103
0.68
0.39
1.4
1.3
—
—
—
0
0
7
105
0.66
0.39
1.0
1.2
—
1.0
—
0
6
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
9.4
—
0
19
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
0
19
0.00
0.39
0.0
3.0
—
24.9
—
0
19
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
11
82
1.35
0.34
1.0
1.1
—
—
—
0
0
21
174
1.21
0.32
1.5
1.5
—
—
—
0
0
7
52
1.35
0.31
1.0
1.5
1.1
1.0
g/l
—
7
52
12
153
0.78
0.31
1.1
1.1
—
7.0
—
0
21
24
203
1.19
0.30
1.4
1.7
—
277.1
—
0
7
7
55
1.28
0.30
1.0
1.2
—
—
—
0
0
7
57
1.23
0.29
1.0
2.5
—
—
—
0
0
9
121
0.74
0.27
1.0
2.1
—
—
—
0
0
11
135
0.81
0.22
1.2
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
5.2
—
0
11
0
11
0.00
0.21
0.0
1.2
—
0.5
—
0
6
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
1.2
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
23
261
0.88
0.20
1.3
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
36
388
0.92
0.14
2.2
2.3
—
22.1
—
0
35
14
157
0.89
0.11
1.1
2.1
12.3
10.5
mg/l
1.53
14
151
13
116
1.12
0.09
1.2
1.6
—
—
—
0
0
30
284
1.06
0.07
1.1
1.2
125.8
140.1
iu/ml
—
6
106
7
84
0.83
0.07
2.9
2.7
19.8
16.8
%
—
7
44
27
256
1.06
0.06
1.4
1.4
12.2
6.1
u/l
0.85
17
214
10
90
1.11
0.05
1.6
1.4
—
—
—
0
0
52
536
0.97
0.05
15.2
11.4
-0.3
1.1
mmol/l
1.51
37
430
10
91
1.10
0.04
1.1
1.7
—
—
—
0
0
10
109
0.92
0.04
1.0
1.2
—
25.6
—
0
8
11
102
1.08
0.03
1.3
1.2
119.6
115.3
%
0.20
11
94
10
108
0.92
0.03
1.3
1.4
—
—
—
0
0
358
3592
0.99
0.02
2.7
3.3
13.6
14.6
pmol/l
14.00
342
3345
109
1098
0.99
0.01
2.3
2.2
—
—
—
0
0
11
116
0.95
0.00
1.2
1.5
—
62.1
—
0
39
13
124
1.05
0.00
1.4
2.3
23.3
31.7
u/ml
0.37
13
118
449
4497
0.99
0.00
3.8
3.8
1.9
2.1
mu/l
0.41
431
4220
11
105
1.05
0.00
1.3
1.2
—
—
—
0
0
26
265
0.98
0.00
1.1
1.1
—
—
—
0
0
53
534
0.99
0.00
15.7
11.3
12.2
12.5
kpa
0.17
47
512
53
534
0.99
0.00
15.7
11.4
5.0
5.2
kpa
0.53
47
509
10
99
1.01
0.00
1.1
1.1
—
—
—
0
0
7
71
0.99
0.00
1.3
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
2.2
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.6
—
0.4
—
0
8
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
24
240
1.00
0.00
1.6
1.6
258.6
261.5
mu/l
0.04
24
223
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
105.3
—
0
6
8
87
0.92
0.00
1.0
2.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_CONDITIONS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_CONDITIONS | 4.108 [2.91, 5.8] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.455 |
During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 643 females with AB1_OTHER_CONDITIONS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_CONDITIONS | 2.837 [2.42, 3.32] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 266 out of 1729 males with AB1_OTHER_CONDITIONS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_CONDITIONS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.439% | 0.538% |
| 5 | 2.69% | 3.498% |
| 10 | 5.971% | 8.836% |
| 15 | 12.195% | 15.784% |
| 20 | 20.703% | 25.317% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_CONDITIONS – Human immunodeficiency virus [HIV] disease resulting in other conditions
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data